查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529674

化学冷光免疫检测市场规模、份额和趋势分析报告：2024-2030 年按产品、应用、最终用途、地区和细分市场进行的预测

Chemiluminescence Immunoassay Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Sample Type (Blood, Urine), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格
简介目录

化学冷光免疫检测市场的成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球化学冷光免疫检测市场规模预计将达到 155 亿美元。

预计2024年至2030年复合年增长率为4.6%。慢性病的高盛行率、化学冷光免疫检测(CLIA) 技术的多项优势以及新型 CLIA 解决方案的核准和推出预计将成为推动市场的主要因素。

新兴市场的主要参与者正在实施有机和无机成长策略来行销、开拓和销售新的 CLIA 解决方案。例如，2020 年 2 月，中国免疫测量製造商 Snibe Diagnostic 的新型 MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA套件获得了 CE 标誌。另一个例子是，2018 年 1 月，DiaSorin 与德国 Qiagen 合作，将 Qiagen 的 QuantiFERON-TB 诊断测试产品组合添加到全自动化学冷光免疫检测分析仪 LIAISON 系列中。领先公司的这些倡议预计将显着促进市场成长。然而，自动化化学冷光免疫检测系统的高设置成本预计将成为限制市场成长的主要因素。

此外，关键地区慢性病的高盛行率以及新兴国家对这些疾病的认识不断提高，预计将推动对新诊断解决方案（包括化学冷光免疫检测）的需求。根据美国癌症协会发布的资料，2020年美国估计新诊断出180万癌症病例，约606,520人因癌症死亡。此外，根据世界卫生组织2020年11月发布的资料，爱滋病毒已成为全球重大公共卫生议题，全球约有3,790万人感染爱滋病毒。

化学冷光免疫检测市场报告亮点

  • 从产品来看，由于治疗药物监测、内分泌和疾病诊断的高需求，耗材将在 2023 年占据市场主导地位。
  • 从应用来看，2023年感染疾病领域占最大。这是由于感染疾病的高盛行率以及用于感染疾病诊断的新型 CLIA 检测方法的推出。
  • 按最终用途划分，由于住院患者数量不断增加以及慢性病患病率上升，医院部门在 2020 年和 2023 年占据最大份额。
  • 在北美地区，美国在2023年占据最大份额。这是由于发达的医疗保健基础设施、技术先进的 CLIA 系统的高采用率以及主要企业的强大地理影响力。
  • 预计亚太地区在预测期内将以最快的复合年增长率扩张。印度和中国等新兴市场的本土企业的崛起主要推动了该区域市场的发展。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章化学冷光免疫检测市场变数、趋势、范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 化学冷光免疫检测市场分析工具
    • 波特的分析
    • PESTEL分析

第四章化学冷光免疫检测市场：按产品估计和趋势分析

  • 细分仪表板
  • 化学冷光免疫检测市场：2023 年和 2030 年按产品分類的变异分析
  • 装置
  • 消耗品
  • 软体和服务

第五章化学冷光免疫检测市场：按样本类型的估计和趋势分析

  • 细分仪表板
  • 化学冷光免疫检测市场：2023 年和 2030 年按样本类型进行的变异分析
  • 血
  • 尿
  • 唾液
  • 其他样品类型

第六章化学冷光免疫检测市场：按应用估算和趋势分析

  • 细分仪表板
  • 化学冷光免疫检测市场：2023 年和 2030 年按应用分类的变化分析
  • 治疗药物监测
  • 肿瘤学
  • 心臟病学
  • 内分泌学
  • 感染疾病
  • 自体免疫疾病
  • 其他用途

第七章化学冷光免疫检测市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 化学冷光免疫检测市场：2023 年和 2030 年最终用途的变化分析
  • 医院
  • 临床实验室
  • 製药和生物技术公司
  • 其他用途

第八章化学冷光免疫检测市场：区域估计和趋势分析

  • 2023 年和 2030 年化学冷光免疫检测市场占有率（按地区）
  • 北美洲
    • 2018-2030年北美化学冷光免疫检测市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲化学冷光免疫检测市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区化学冷光免疫检测估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲化学冷光免疫检测市场估计与预测
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲化学冷光免疫检测市场估计和预测，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • DiaSorin SpA
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers
    • Ortho Clinical Diagnostics
简介目录
Product Code: GVR-4-68039-152-8

Chemiluminescence Immunoassay Market Growth & Trends:

The global chemiluminescence immunoassay market size is expected to reach USD 15.50 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.6% from 2024 to 2030. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen's QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.

Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.

Chemiluminescence Immunoassay Market Report Highlights:

  • Based on product, consumables dominated the market in 2023 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
  • In terms of application, the infectious disease segment held the largest share in 2023 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
  • By end use, in 2020, the hospitals segment accounted for the largest share in 2023 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
  • In North America, the U.S. held the largest share in 2023 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
  • Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Chemiluminescence Immunoassay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Chemiluminescence Immunoassay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Chemiluminescence Immunoassay Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Chemiluminescence Immunoassay Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Automated
      • 4.3.2.1. Automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Semi-automated
      • 4.3.3.1. Semi-automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software & Services
    • 4.5.1. Software & Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Chemiluminescence Immunoassay Market: Sample Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Chemiluminescence Immunoassay Market: Sample Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Blood
    • 5.3.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Urine
    • 5.4.1. Urine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Saliva
    • 5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Other Sample Types
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Chemiluminescence Immunoassay Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Chemiluminescence Immunoassay Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Therapeutic Drug Monitoring
    • 6.3.1. Therapeutic Drug Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Cardiology
    • 6.5.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Endocrinology
    • 6.6.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Autoimmune Disease
    • 6.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Other Applications
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Chemiluminescence Immunoassay Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Chemiluminescence Immunoassay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Clinical Laboratories
    • 7.4.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Pharmaceutical & Biotechnology Companies
    • 7.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Other End Uses
    • 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Chemiluminescence Immunoassay Market: Regional Estimates & Trend Analysis

  • 8.1. Chemiluminescence Immunoassay Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Abbott Laboratories
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/Strategic Initiatives
    • 9.4.2. Beckman Coulter Inc.
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/Strategic Initiatives
    • 9.4.3. DiaSorin S.p.A.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/Strategic Initiatives
    • 9.4.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/Strategic Initiatives
    • 9.4.5. F. Hoffmann-La Roche AG
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/Strategic Initiatives
    • 9.4.6. Siemens Healthineers
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/Strategic Initiatives
    • 9.4.7. Ortho Clinical Diagnostics
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/Strategic Initiatives